FDA 483 - RLC Labs Inc. - March 05, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
RLC Labs Inc. in Phoenix, AZ, a drug product manufacturer, was inspected and found to have significant deficiencies across its quality system, production, and material controls. The firm lacks a functional quality control unit, proper stability testing, validated specifications, and adequate complaint handling, indicating a broad failure to adhere to GMP regulations. These issues raise concerns about the identity, strength, quality, and purity of its drug products, including Nature-Throid and WP Thyroid.
ID · b0600bfd-f720-4bf2-a5bf-07bf9a1b95ba